skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi Peter and team. I am thinking about buying Difference Capital. The share price has fallen quite low here. Do you have an opinion on them now that they have released 2013 financials? My feeling is that they are just setting up investments and taking losses to position themselves for the long term. I would look to hold 3-4 years. They have just added the former CEO of Descartes to their board and they seem to have a team of tech heavyweights on their team. Is there any problem that you foresee or warnings against this type of investment? Thanks!
Read Answer Asked by Michael on April 03, 2014
Q: Alter NRG Corp

I am down 15% which (with a small position of $1,000) isn't that big a deal. And I know you mentioned in the past this needs to be considered risky. I don't have a problem holding unless there is something you know or can see which should tell me to get out now.

Thank You Peter & Family

Gord
Read Answer Asked by Gord on April 02, 2014
Q: Good Afternoon 5i,

Your thoughts on Brookfield real estate (BRE)?

Thanks
Read Answer Asked by Paul on April 01, 2014
Q: Do you have any news on ICP? I am trying to clean up my portfolio and have taken quite a loss on a few stocks, this being one of them. Any advise? Thank-you!
Read Answer Asked by Denis on April 01, 2014
Q: Hello Peter & Co.
I came across yesterday with 2 names that aroused my interest.
One of them is Knight Therapeutics (GUD-V); same team as Paladin Labs and our Pharma sector in Canada is very limited.
The other is Kelso Technologies (KLS-V) which produces among other things pressure release valves; a very topical subject related to railcar safety.
Could you please comment on them?
Thanks,
Tony
Read Answer Asked by Antoine on April 01, 2014
Q: What is your overall assessment on dap.u xpel technologies earnings realease.
Read Answer Asked by samuel on April 01, 2014
Q: I have seen the discussion on Molycorp mcp, which goes back to Jan 2013 and did not encourage purchasing. How is it now, but, more generally, is there anything in rare earths that should be considered?
Read Answer Asked by Gregory on April 01, 2014
Q: Dear Peter and Team: What do you think of Kelso's (KLS) results and prospects?
Read Answer Asked by Roland on April 01, 2014
Q: Just wondering if you have any thoughts on ICP? I have held it for some time now and have taken a loss. I am considering selling it. Thank-you!
Read Answer Asked by Denis on April 01, 2014
Q: Dear Team:' I would like your opinion about intellipharmaceuticals please. The ticker is I on the TSX. It currently trades at $4.72. Jean
Read Answer Asked by jean on April 01, 2014
Q: What is your view on US GEOTHERMALS earning and the outlook for the future.
Tom
Read Answer Asked by Tom on April 01, 2014
Q: E - Can you comment on their latest earnings and how it compares to market expectations. Thanks.
Read Answer Asked by wendy on April 01, 2014
Q: Would much appreciate your analysis of Aeterna Zentaris(aez).Thanks for your insight.
Read Answer Asked by Maurice on March 31, 2014
Q: Good morning,

Agjunction (AJX) recently reported earnings. May I please have your comments on it and is it an opportunity to enter this stock.

Thanks for your great service.

Doug
Read Answer Asked by Doug on March 31, 2014
Q: Hello Dynacor (DNG) just reported today and the numbers look quite good to me. I would appreciate your take on this company and their 2013 results
As always very much appreciate your service
Read Answer Asked by Robert on March 31, 2014
Q: Hi Peter, a very illiquid stock, Senvest (SEC.to) is showing huge earnings, trades at only 2x or so right now. Any thoughts on this co, is it just too illiquid to touch or is it worth a taste.

Thanks a lot
Read Answer Asked by Christopher on March 31, 2014
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!